Literature DB >> 21681550

Coll2-1, Coll2-1NO2 and myeloperoxidase concentrations in the synovial fluid of equine tarsocrural joints affected with osteochondrosis.

Denis R Verwilghen1, Ann Martens, Evita Busschers, Thierry Franck, Michelle Deberg, Yves Henrotin, Laurent Vanderheyden, Didier Serteyn.   

Abstract

The measurement of biomarkers that reflect cartilage breakdown is a powerful tool for investigating joint damage caused by disease or injury. Particularly in cases of osteochondrosis, synovial concentrations of these biomarkers may reveal the presence of osteoarthritic changes. Coll2-1, Coll2-1 NO2 and myeloperoxidase have recently been introduced in equine osteoarticular research but comparison between the concentrations of these markers in OCD affected and healthy joints has not been made. Therefore, this study aimed at reporting the synovial concentrations of these biomarkers in joints affected with osteochondral fragments in the tarsocrural joint compared to unaffected joints. Myeloperoxidase and Coll2-1NO2 revealed to have similar levels between affected joints and controls. However, in contrast to previous studies using C2C the present study demonstrated that synovial levels of Coll2-1 were significantly elevated in tarsocrural joints affected with osteochondrosis. Thus, Coll2-1 may be an earlier marker of cartilage degeneration than other cartilage degradation markers that have been previously used in equine medicine.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21681550     DOI: 10.1007/s11259-011-9487-5

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  38 in total

Review 1.  Classification of osteoarthritis biomarkers: a proposed approach.

Authors:  D C Bauer; D J Hunter; S B Abramson; M Attur; M Corr; D Felson; D Heinegård; J M Jordan; T B Kepler; N E Lane; T Saxne; B Tyree; V B Kraus
Journal:  Osteoarthritis Cartilage       Date:  2006-06-02       Impact factor: 6.576

Review 2.  Biomarkers of cartilage turnover. Part 1: Markers of collagen degradation and synthesis.

Authors:  Elaine R Garvican; Anne Vaughan-Thomas; John F Innes; Peter D Clegg
Journal:  Vet J       Date:  2010-05-21       Impact factor: 2.688

3.  A type II-collagen derived peptide and its nitrated form as new markers of inflammation and cartilage degradation in equine osteochondral lesions.

Authors:  M Gangl; D Serteyn; J-Ph Lejeune; N Schneider; S Grulke; F Peters; T Vila; G Deby-Dupont; M Deberg; Y Henrotin
Journal:  Res Vet Sci       Date:  2006-06-14       Impact factor: 2.534

4.  NMR studies on human, pathologically changed synovial fluids: role of hypochlorous acid.

Authors:  J Schiller; J Arnhold; K Sonntag; K Arnold
Journal:  Magn Reson Med       Date:  1996-06       Impact factor: 4.668

5.  Plasma concentrations of myeloperoxidase in endurance and 3-day event horses after a competition.

Authors:  T Art; T Franck; M Gangl; D Votion; S Kohnen; G Deby-Dupont; D Serteyn
Journal:  Equine Vet J Suppl       Date:  2006-08

6.  A tale of two controversies: defining both the role of peroxidases in nitrotyrosine formation in vivo using eosinophil peroxidase and myeloperoxidase-deficient mice, and the nature of peroxidase-generated reactive nitrogen species.

Authors:  Marie-Luise Brennan; Weijia Wu; Xiaoming Fu; Zhongzhu Shen; Wei Song; Heather Frost; Caryn Vadseth; Laura Narine; Elizabeth Lenkiewicz; Michael T Borchers; Aldons J Lusis; James J Lee; Nancy A Lee; Husam M Abu-Soud; Harry Ischiropoulos; Stanley L Hazen
Journal:  J Biol Chem       Date:  2002-02-27       Impact factor: 5.157

7.  Myeloperoxidase and chlorinated peptides in osteoarthritis: potential biomarkers of the disease.

Authors:  Marla J Steinbeck; Leon J Nesti; Peter F Sharkey; Javad Parvizi
Journal:  J Orthop Res       Date:  2007-09       Impact factor: 3.494

8.  Relationship between biochemical markers and radiographic scores in the evaluation of the osteoarticular status of Warmblood stallions.

Authors:  Denis Verwilghen; Valeria Busoni; Monika Gangl; Thierry Franck; Jean-Philippe Lejeune; Laurent Vanderheyden; Johann Detilleux; Sigrid Grulke; Michelle Deberg; Yves Henrotin; Didier Serteyn
Journal:  Res Vet Sci       Date:  2009-03-18       Impact factor: 2.534

9.  Evaluation of serum concentrations of biomarkers of skeletal metabolism and results of radiography as indicators of severity of osteochondrosis in foals.

Authors:  R Clark Billinghurst; Pieter A J Brama; P Rene van Weeren; Megan S Knowlton; C Wayne McIlwraith
Journal:  Am J Vet Res       Date:  2004-02       Impact factor: 1.156

10.  Depolymerization of synovial fluid hyaluronic acid (HA) by the complete myeloperoxidase (MPO) system may involve the formation of a HA-MPO ionic complex.

Authors:  S P Green; M S Baker; D A Lowther
Journal:  J Rheumatol       Date:  1990-12       Impact factor: 4.666

View more
  4 in total

1.  Review of Soluble Biomarkers of Osteoarthritis: Lessons From Animal Models.

Authors:  Catherine B Legrand; Cécile J Lambert; Fanny V Comblain; Christelle Sanchez; Yves E Henrotin
Journal:  Cartilage       Date:  2016-07-07       Impact factor: 4.634

Review 2.  Osteochondritis dissecans (OCD) in Horses - Molecular Background of its Pathogenesis and Perspectives for Progenitor Stem Cell Therapy.

Authors:  Lynda Bourebaba; Michael Röcken; Krzysztof Marycz
Journal:  Stem Cell Rev Rep       Date:  2019-06       Impact factor: 5.739

3.  Effect of Resveratrol on Serum Levels of Type II Collagen and Aggrecan in Patients with Knee Osteoarthritis: A Pilot Clinical Study.

Authors:  Bushra Hassan Marouf
Journal:  Biomed Res Int       Date:  2021-11-11       Impact factor: 3.411

4.  Decrease of a specific biomarker of collagen degradation in osteoarthritis, Coll2-1, by treatment with highly bioavailable curcumin during an exploratory clinical trial.

Authors:  Yves Henrotin; Myriam Gharbi; Yvan Dierckxsens; Fabian Priem; Marc Marty; Laurence Seidel; Adelin Albert; Elisabeth Heuse; Valérie Bonnet; Caroline Castermans
Journal:  BMC Complement Altern Med       Date:  2014-05-17       Impact factor: 3.659

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.